Business Description
Ramsay Health Care Ltd
ISIN : AU0000RHCPA4
Share Class Description:
ASX:RHCPA.PFD: Non-cumulative red conv pref shs 2005-Without Fixed Maturity VRN on CaresTotal Employee Number:
88,000Compare
Compare
Traded in other countries / regions
RHC.AustraliaRMYHY.USARMY.Germany IPO Date
2005-05-24Description
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.24 | |||||
Debt-to-Equity | 2.22 | |||||
Debt-to-EBITDA | 5.46 | |||||
Interest Coverage | 2.82 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.65 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7 | |||||
3-Year EBITDA Growth Rate | 3.7 | |||||
3-Year EPS without NRI Growth Rate | 5.4 | |||||
3-Year FCF Growth Rate | 7.1 | |||||
3-Year Book Growth Rate | 5.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 16.37 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.97 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.16 | |||||
9-Day RSI | 50.14 | |||||
14-Day RSI | 51.22 | |||||
3-1 Month Momentum % | 1.13 | |||||
6-1 Month Momentum % | 0.99 | |||||
12-1 Month Momentum % | -0.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.91 | |||||
Quick Ratio | 0.81 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 35.99 | |||||
Days Sales Outstanding | 51.22 | |||||
Days Payable | 151 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.59 | |||||
3-Year Dividend Growth Rate | -5.7 | |||||
Forward Dividend Yield % | 6.22 | |||||
5-Year Yield-on-Cost % | 5.85 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 3.78 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 77.63 | |||||
Operating Margin % | 4.86 | |||||
Net Margin % | 1.78 | |||||
EBITDA Margin % | 10.91 | |||||
ROE % | 6.57 | |||||
ROA % | 1.52 | |||||
ROIC % | 2.87 | |||||
3-Year ROIIC % | 13.65 | |||||
ROC (Joel Greenblatt) % | 7.75 | |||||
ROCE % | 4.75 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 39.39 | |||||
Forward PE Ratio | 24.5 | |||||
PE Ratio without NRI | 38.16 | |||||
Shiller PE Ratio | 25.17 | |||||
Price-to-Owner-Earnings | 11.76 | |||||
PEG Ratio | 31.8 | |||||
PS Ratio | 0.7 | |||||
PB Ratio | 2.49 | |||||
Price-to-Free-Cash-Flow | 18.59 | |||||
Price-to-Operating-Cash-Flow | 9.06 | |||||
EV-to-EBIT | 27.97 | |||||
EV-to-EBITDA | 11.56 | |||||
EV-to-Revenue | 1.26 | |||||
EV-to-FCF | 33.41 | |||||
Earnings Yield (Greenblatt) % | 3.58 | |||||
FCF Yield % | 5.63 | |||||
Forward Rate of Return (Yacktman) % | 5.62 |
GF Valueâ„¢
Ramsay Health Care Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ramsay Health Care Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2027-02-26 | In 165 days | ||
| Second quarter earnings conference call for 2027 | 2027-02-26 | In 165 days | ||
| General meeting for 2026 | 2026-11-24 | In 71 days | ||
| AUD 3.360800 Cash Dividend | 2026-09-29 | In 15 days | ||
| Annual report for 2026 | 2026-09-18 | In 4 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-27 10:00 | 108.65 (+1.00%) | ||
| Fourth quarter earnings results for 2026 | 2026-08-27 | 108.65 (+1.00%) | ||
| AUD 2.964200 Cash Dividend | 2026-04-02 | 107.85 (+0.78%) | ||
| Second quarter earnings conference call for 2026 | 2026-02-26 | 107.15 (-0.11%) | ||
| Second quarter earnings results for 2026 | 2026-02-26 | 107.15 (-0.11%) |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers